Featured Research

from universities, journals, and other organizations

New clinical practice guidelines for overactive bladder, urodynamics, hematuria, and vasectomy

Date:
October 24, 2012
Source:
Elsevier
Summary:
The American Urological Association introduces new clinical guidelines for the treatment of overactive bladder, urodynamics, hematuria, and vasectomy. The guidelines, which were developed using a rigorous nine-step process to synthesize and summarize the literature to determine the level and quality of evidence for a certain practice.

The American Urological Association (AUA) introduces new clinical guidelines for the treatment of Overactive Bladder, Urodynamics, Hematuria, and Vasectomy. The guidelines, which were developed using a rigorous 9-step process to synthesize and summarize the literature to determine the level and quality of evidence for a certain practice, are published in a supplement to the December issue of The Journal of Urology®.

"These guidelines are a great resource not only to AUA members, but also to physicians and patients worldwide," says J. Stuart Wolf, Jr., MD, Chair, AUA Practice Guidelines Committee. "Some variation in treatment is appropriate for any number of reasons, but much of the variation in patient care is undesirable and reduces the quality of health care. The guidelines, if read carefully and applied to practice, will improve the quality of patient care."

The new guideline on the diagnosis and treatment of overactive bladder is based on a systematic review commissioned by the Agency on Healthcare Research and Quality. It was produced by an 11-member collaborative multidisciplinary panel convened by the AUA and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. The collaboration also produced the guideline on adult urodynamics. This guideline elucidates the principles of selection and performance of urodynamic tests, based on the evidence in 393 published articles.

The guideline for the diagnosis, evaluation, and followup of asymptomatic microhematuria, in which red blood cells appear in urine and may be related to a number of conditions such as kidney stones or urinary tract infection, is useful to primary care physicians as well as urologists. This guideline is a revision of an earlier "best practice" document from the AUA. It reflects significant changes, including a reduction in the number of urinalyses required to determine need for evaluation, the preferred radiological imaging, and followup.

The AUA guideline on vasectomy was produced by a panel of eight, including a specialist in preventive medicine and a family medicine physician. The panel reviewed 284 articles published from 1949 to 2011. This guideline includes clear and concise statements that will help standardize and improve care for vasectomy patients by urologists and other vasectomy providers.

"It can be difficult to sift through the vast repository of clinical information to decide what the most cost- effective care is," says journal Editor-in-Chief William D. Steers, MD. "I am proud that The Journal of Urology® serves as a platform to disseminate these valuable documents to the urological community in the United States and abroad."


Story Source:

The above story is based on materials provided by Elsevier. Note: Materials may be edited for content and length.


Journal References:

  1. J. Stuart Wolf. Introduction. The Journal of Urology, 2012; DOI: 10.1016/j.juro.2012.10.010
  2. E. Ann Gormley, Deborah J. Lightner, Kathryn L. Burgio, Toby C. Chai, J. Quentin Clemens, Daniel J. Culkin, Anurag Kumar Das, Harris Emilio Foster, Harriette Miles Scarpero, Christopher D. Tessier, Sandip Prasan Vasavada. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline. The Journal of Urology, 2012; DOI: 10.1016/j.juro.2012.09.079
  3. J. Christian Winters, Roger R. Dmochowski, Howard B. Goldman, C.D. Anthony Herndon, Kathleen C. Kobashi, Stephen R. Kraus, Gary E. Lemack, Victor W. Nitti, Eric S. Rovner, Alan J. Wein. Urodynamic Studies in Adults: AUA/SUFU Guideline. The Journal of Urology, 2012; DOI: 10.1016/j.juro.2012.09.081
  4. R. Davis, J. S. Jones, D. A. Barocas, E. P. Castle, E. K. Lang, R. J. Leveillee, E. M. Messing, S. C. Miller, A. C. Peterson, T. M. T. Turk and W. Weitzel. Diagnosis, Evaluation and Followu p of Asymptomatic Microhematuria in Adults: AUA Guideline. The Journal of Urology, 2012
  5. Ira D. Sharlip, Arnold M. Belker, Stanton Honig, Michel Labrecque, Joel L. Marmar, Lawrence S. Ross, Jay I. Sandlow, David C. Sokal. Vasectomy: AUA Guideline. The Journal of Urology, 2012; DOI: 10.1016/j.juro.2012.09.080

Cite This Page:

Elsevier. "New clinical practice guidelines for overactive bladder, urodynamics, hematuria, and vasectomy." ScienceDaily. ScienceDaily, 24 October 2012. <www.sciencedaily.com/releases/2012/10/121024093308.htm>.
Elsevier. (2012, October 24). New clinical practice guidelines for overactive bladder, urodynamics, hematuria, and vasectomy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/10/121024093308.htm
Elsevier. "New clinical practice guidelines for overactive bladder, urodynamics, hematuria, and vasectomy." ScienceDaily. www.sciencedaily.com/releases/2012/10/121024093308.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins